We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRMW
3076
DELISTED
Primo Water Corporation
PRMW
$52K ﹤0.01%
10,825
-1,082
-9% -$4.64K
HNR
3077
DELISTED
Harvest Natural Resources
HNR
$51K ﹤0.01%
+2,545
New +$47.5K
STRR
3078
Star Equity Holdings
STRR
$39.9M
$50K ﹤0.01%
1,277
-128
-9% -$4.72K
RSYS
3079
DELISTED
Radisys Corp
RSYS
$50K ﹤0.01%
14,253
-8,476
-37% -$27.4K
FXEN
3080
DELISTED
FX ENERGY INC
FXEN
$50K ﹤0.01%
13,736
-1,246
-8% -$5.07K
URZ
3081
DELISTED
URANERZ ENERGY CORP
URZ
$50K ﹤0.01%
33,628
-3,362
-9% -$5.08K
CYNI
3082
DELISTED
CYAN INC COM
CYNI
$48K ﹤0.01%
+11,841
New +$47.4K
WYY icon
3083
WidePoint Corp
WYY
$101M
$47K ﹤0.01%
2,649
-265
-9% -$3.95K
ATEC icon
3084
Alphatec Holdings
ATEC
$1.46B
$46K ﹤0.01%
2,334
-1,117
-32% -$18.8K
NOR
3085
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$46K ﹤0.01%
+1,869
New +$46.7K
CPRX
3086
DELISTED
Catalyst Pharmaceutical
CPRX
$45K ﹤0.01%
17,744
-1,774
-9% -$3.79K
BXC icon
3087
BlueLinx
BXC
$422M
$44K ﹤0.01%
3,129
-509
-14% -$6.59K
CTLP
3088
DELISTED
Cantaloupe
CTLP
$44K ﹤0.01%
21,043
-2,104
-9% -$4.24K
MEET
3089
DELISTED
The Meet Group, Inc. Common Stock
MEET
$44K ﹤0.01%
16,188
-1,618
-9% -$4.03K
AMRS
3090
DELISTED
Amyris Inc.
AMRS
$43K ﹤0.01%
+761
New +$39.9K
EMMS
3091
DELISTED
Emmis Communications Corp
EMMS
$43K ﹤0.01%
3,809
-381
-9% -$4.37K
GROW icon
3092
US Global Investors
GROW
$35.5M
$42K ﹤0.01%
12,041
-1,204
-9% -$4.15K
MBOT icon
3093
Microbot Medical
MBOT
$116M
$42K ﹤0.01%
13
-1
-7% -$2.31K
AVEO
3094
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$42K ﹤0.01%
2,298
-991
-30% -$12.9K
NSPH
3095
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$42K ﹤0.01%
1,327
-467
-26% -$15K
INOD icon
3096
Innodata
INOD
$2.05B
$41K ﹤0.01%
12,731
-1,272
-9% -$3.86K
TST
3097
DELISTED
TheStreet, Inc.
TST
$41K ﹤0.01%
1,701
-170
-9% -$4.31K
AXTI icon
3098
AXT Inc
AXTI
$3.95B
$40K ﹤0.01%
18,507
-1,850
-9% -$4.04K
ALT icon
3099
Altimmune
ALT
$552M
$39K ﹤0.01%
92
-9
-9% -$4.07K
ULBI icon
3100
Ultralife
ULBI
$86.4M
$39K ﹤0.01%
10,125
-1,012
-9% -$3.88K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.